I am from EU, especially one of those countries with free health care. I believe we have a mix of public research, private research (ex: Sanofi, Servier), expensive proprietary drugs and government controlled public domain generic drugs. But there was an alert recently on drug making sovereignty because no company is interested in making those less profitable generic drugs in France, so they are outsourced to cheaper countries and there’s a risk of penury.
Maybe choosing your poison? Viber belongs to the Japanese company Rakuten, so it may be more interesting geopolitically, depending on your country.